Pandemic Covid-19 has brought havoc in our lives.
While we return to our normal life, it is very important to follow the Covid-19 protocol and vaccinate to protect ourselves from the deadly virus.
At present, the only protection against Covid-19 is a vaccine.
There is good news for people who are afraid to be injected.
In the future, vaccines may come in the form of inhalers and even pills.
Yes, you read it correctly.
Here more about covid vaccines in the form of inhalers.
In the Laboratory in Medicon Village, which is one of the largest science parks in South Sweden, chemist Ingemo Andreson creates a thin, plastic inhaler, only the size of a matchbox, which will immunize people against the Covid-19 virus.
In accordance with his team, this inhaler can play a big role in fighting global pandemics by allowing people to take the powder version of the vaccine at home, in the future.
The inhaler is very cheap and easy to produce.
Someone can take it just by removing a small plastic slip, which activates inhaler.
You just put it in the mouth, take a deep breath and take a breath.
The company called Iconovo collaborated with the start-up of immunological research in Stockholm, ISR, which has developed a dry powder vaccine against Covid-19.
This powder uses Covid-19 virus protein produced and can withstand temperatures up to 40C.
This powder is a game-changer because you can distribute it very easily without the need for health care providers.
It also does not need to be stored at cold temperatures in glass bottles, unlike vaccine shots.
The company is currently testing its vaccine on the Beta (South Africa) and Alpha (UK) variants of Covid-19.
This can speed up the process of launch vaccines in Africa where no vaccines planted at home and warmer temperatures make it more challenging, because of making storage and providing a difficult vaccine.
The dry vaccine still needs to go through various trials to find out the full potential and to find out whether it is as effective with a vaccine list provided by WHO.
So far, it has only been tested in mice, even though the study of humans is expected to begin within two months.
If successful, the powder vaccine can revolutionize the global response to the coronavirus pandemic.
More people can be saved and immunized against viruses.